CN104839718A - Powder-form full-nutrient formula food and production process thereof - Google Patents
Powder-form full-nutrient formula food and production process thereof Download PDFInfo
- Publication number
- CN104839718A CN104839718A CN201510273213.6A CN201510273213A CN104839718A CN 104839718 A CN104839718 A CN 104839718A CN 201510273213 A CN201510273213 A CN 201510273213A CN 104839718 A CN104839718 A CN 104839718A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- powder
- protein
- acid
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title abstract description 23
- 238000004519 manufacturing process Methods 0.000 title abstract description 5
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 51
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 51
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 30
- 235000015097 nutrients Nutrition 0.000 claims abstract description 26
- 229940088594 vitamin Drugs 0.000 claims abstract description 15
- 229930003231 vitamin Natural products 0.000 claims abstract description 15
- 235000013343 vitamin Nutrition 0.000 claims abstract description 15
- 239000011782 vitamin Substances 0.000 claims abstract description 15
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 14
- 235000010755 mineral Nutrition 0.000 claims abstract description 14
- 239000011707 mineral Substances 0.000 claims abstract description 14
- 238000012216 screening Methods 0.000 claims abstract description 5
- 235000016709 nutrition Nutrition 0.000 claims description 54
- 235000018102 proteins Nutrition 0.000 claims description 49
- 102000008186 Collagen Human genes 0.000 claims description 47
- 108010035532 Collagen Proteins 0.000 claims description 47
- 229920001436 collagen Polymers 0.000 claims description 47
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 36
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 34
- 239000000203 mixture Substances 0.000 claims description 34
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 32
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 32
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 32
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 32
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 32
- 235000014633 carbohydrates Nutrition 0.000 claims description 28
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 26
- 239000004615 ingredient Substances 0.000 claims description 26
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 24
- 239000011575 calcium Substances 0.000 claims description 24
- 229910052791 calcium Inorganic materials 0.000 claims description 24
- 235000001465 calcium Nutrition 0.000 claims description 24
- 235000019197 fats Nutrition 0.000 claims description 23
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 22
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 22
- 108010073771 Soybean Proteins Proteins 0.000 claims description 22
- 239000000460 chlorine Substances 0.000 claims description 22
- 229910052801 chlorine Inorganic materials 0.000 claims description 22
- 239000011669 selenium Substances 0.000 claims description 22
- 229910052711 selenium Inorganic materials 0.000 claims description 22
- 235000019710 soybean protein Nutrition 0.000 claims description 22
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 21
- 229910052802 copper Inorganic materials 0.000 claims description 21
- 239000010949 copper Substances 0.000 claims description 21
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 20
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 20
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 20
- 239000011777 magnesium Substances 0.000 claims description 20
- 229910052749 magnesium Inorganic materials 0.000 claims description 20
- 239000011591 potassium Substances 0.000 claims description 20
- 229910052700 potassium Inorganic materials 0.000 claims description 20
- 229910052708 sodium Inorganic materials 0.000 claims description 20
- 239000011734 sodium Substances 0.000 claims description 20
- 241000251468 Actinopterygii Species 0.000 claims description 19
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 19
- 239000011701 zinc Substances 0.000 claims description 19
- 229910052725 zinc Inorganic materials 0.000 claims description 19
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 18
- 229910052742 iron Inorganic materials 0.000 claims description 18
- 239000011574 phosphorus Substances 0.000 claims description 18
- 229910052698 phosphorus Inorganic materials 0.000 claims description 18
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 17
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 17
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 17
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 17
- 229930003427 Vitamin E Natural products 0.000 claims description 17
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 17
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 17
- 150000002617 leukotrienes Chemical class 0.000 claims description 17
- 235000020778 linoleic acid Nutrition 0.000 claims description 17
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 17
- 235000019155 vitamin A Nutrition 0.000 claims description 17
- 239000011719 vitamin A Substances 0.000 claims description 17
- 235000019165 vitamin E Nutrition 0.000 claims description 17
- 239000011709 vitamin E Substances 0.000 claims description 17
- 229940046009 vitamin E Drugs 0.000 claims description 17
- 229940045997 vitamin a Drugs 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 16
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 16
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 16
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 claims description 16
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 16
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 16
- 229930003451 Vitamin B1 Natural products 0.000 claims description 16
- 229930003779 Vitamin B12 Natural products 0.000 claims description 16
- 229930003471 Vitamin B2 Natural products 0.000 claims description 16
- 229930003268 Vitamin C Natural products 0.000 claims description 16
- 229930003316 Vitamin D Natural products 0.000 claims description 16
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 16
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 16
- 229960000304 folic acid Drugs 0.000 claims description 16
- 235000019152 folic acid Nutrition 0.000 claims description 16
- 239000011724 folic acid Substances 0.000 claims description 16
- 229960003512 nicotinic acid Drugs 0.000 claims description 16
- 235000001968 nicotinic acid Nutrition 0.000 claims description 16
- 239000011664 nicotinic acid Substances 0.000 claims description 16
- 229940055726 pantothenic acid Drugs 0.000 claims description 16
- 235000019161 pantothenic acid Nutrition 0.000 claims description 16
- 239000011713 pantothenic acid Substances 0.000 claims description 16
- 235000019175 phylloquinone Nutrition 0.000 claims description 16
- 239000011772 phylloquinone Substances 0.000 claims description 16
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 16
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 claims description 16
- 229960001898 phytomenadione Drugs 0.000 claims description 16
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 16
- 229960002477 riboflavin Drugs 0.000 claims description 16
- 229960003495 thiamine Drugs 0.000 claims description 16
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 16
- 235000010374 vitamin B1 Nutrition 0.000 claims description 16
- 239000011691 vitamin B1 Substances 0.000 claims description 16
- 235000019163 vitamin B12 Nutrition 0.000 claims description 16
- 239000011715 vitamin B12 Substances 0.000 claims description 16
- 235000019164 vitamin B2 Nutrition 0.000 claims description 16
- 239000011716 vitamin B2 Substances 0.000 claims description 16
- 235000019158 vitamin B6 Nutrition 0.000 claims description 16
- 239000011726 vitamin B6 Substances 0.000 claims description 16
- 235000019154 vitamin C Nutrition 0.000 claims description 16
- 239000011718 vitamin C Substances 0.000 claims description 16
- 235000019166 vitamin D Nutrition 0.000 claims description 16
- 239000011710 vitamin D Substances 0.000 claims description 16
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 16
- 229940011671 vitamin b6 Drugs 0.000 claims description 16
- 229940046008 vitamin d Drugs 0.000 claims description 16
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 15
- 239000002131 composite material Substances 0.000 claims description 15
- 239000011630 iodine Substances 0.000 claims description 15
- 229910052740 iodine Inorganic materials 0.000 claims description 15
- 229910052748 manganese Inorganic materials 0.000 claims description 15
- 239000011572 manganese Substances 0.000 claims description 15
- 235000013336 milk Nutrition 0.000 claims description 15
- 239000008267 milk Substances 0.000 claims description 15
- 210000004080 milk Anatomy 0.000 claims description 15
- 239000005913 Maltodextrin Substances 0.000 claims description 14
- 229920002774 Maltodextrin Polymers 0.000 claims description 14
- 229940035034 maltodextrin Drugs 0.000 claims description 14
- 229920001592 potato starch Polymers 0.000 claims description 14
- 235000007164 Oryza sativa Nutrition 0.000 claims description 13
- 235000019483 Peanut oil Nutrition 0.000 claims description 13
- 229930006000 Sucrose Natural products 0.000 claims description 13
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 13
- 229960002685 biotin Drugs 0.000 claims description 13
- 235000020958 biotin Nutrition 0.000 claims description 13
- 239000011616 biotin Substances 0.000 claims description 13
- 239000000312 peanut oil Substances 0.000 claims description 13
- 235000009566 rice Nutrition 0.000 claims description 13
- 239000003549 soybean oil Substances 0.000 claims description 13
- 235000012424 soybean oil Nutrition 0.000 claims description 13
- 239000005720 sucrose Substances 0.000 claims description 13
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 12
- 235000019484 Rapeseed oil Nutrition 0.000 claims description 9
- 238000005516 engineering process Methods 0.000 claims description 9
- 239000011159 matrix material Substances 0.000 claims description 9
- 150000004667 medium chain fatty acids Chemical class 0.000 claims description 9
- 230000001954 sterilising effect Effects 0.000 claims description 9
- 238000004659 sterilization and disinfection Methods 0.000 claims description 9
- 102000002322 Egg Proteins Human genes 0.000 claims description 8
- 108010000912 Egg Proteins Proteins 0.000 claims description 8
- 241000272496 Galliformes Species 0.000 claims description 8
- 235000019482 Palm oil Nutrition 0.000 claims description 8
- 235000019498 Walnut oil Nutrition 0.000 claims description 8
- 239000003240 coconut oil Substances 0.000 claims description 8
- 235000019864 coconut oil Nutrition 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 239000002540 palm oil Substances 0.000 claims description 8
- 239000008170 walnut oil Substances 0.000 claims description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- 244000144977 poultry Species 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 238000000227 grinding Methods 0.000 claims description 6
- -1 linoleic acid, leukotrienes Chemical class 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 3
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- 240000007594 Oryza sativa Species 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 abstract description 25
- 239000002994 raw material Substances 0.000 abstract description 6
- 201000010099 disease Diseases 0.000 abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 5
- 230000036541 health Effects 0.000 abstract description 5
- 230000036039 immunity Effects 0.000 abstract description 4
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 230000029087 digestion Effects 0.000 abstract description 3
- 230000007774 longterm Effects 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 238000002156 mixing Methods 0.000 abstract description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 abstract 1
- 239000008158 vegetable oil Substances 0.000 abstract 1
- 229960005069 calcium Drugs 0.000 description 21
- 241000699666 Mus <mouse, genus> Species 0.000 description 18
- 229940091250 magnesium supplement Drugs 0.000 description 17
- 229960003975 potassium Drugs 0.000 description 17
- 230000006870 function Effects 0.000 description 12
- 241000209094 Oryza Species 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 9
- 230000004060 metabolic process Effects 0.000 description 9
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 8
- 230000037396 body weight Effects 0.000 description 7
- 239000002253 acid Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 210000004698 lymphocyte Anatomy 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 230000035755 proliferation Effects 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 239000001110 calcium chloride Substances 0.000 description 4
- 229910001628 calcium chloride Inorganic materials 0.000 description 4
- 239000001506 calcium phosphate Substances 0.000 description 4
- 229910000389 calcium phosphate Inorganic materials 0.000 description 4
- 229960001714 calcium phosphate Drugs 0.000 description 4
- 235000011010 calcium phosphates Nutrition 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 230000002354 daily effect Effects 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 230000036737 immune function Effects 0.000 description 4
- 238000002372 labelling Methods 0.000 description 4
- 210000002540 macrophage Anatomy 0.000 description 4
- 210000001616 monocyte Anatomy 0.000 description 4
- 230000035790 physiological processes and functions Effects 0.000 description 4
- 239000001103 potassium chloride Substances 0.000 description 4
- 235000011164 potassium chloride Nutrition 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 4
- 101000693916 Gallus gallus Albumin Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 235000020776 essential amino acid Nutrition 0.000 description 3
- 239000003797 essential amino acid Substances 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000000242 pagocytic effect Effects 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 241000252234 Hypophthalmichthys nobilis Species 0.000 description 2
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 2
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 102000057297 Pepsin A Human genes 0.000 description 2
- 108090000284 Pepsin A Proteins 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 2
- 230000009102 absorption Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000003143 atherosclerotic effect Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000003925 brain function Effects 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 229960003563 calcium carbonate Drugs 0.000 description 2
- 235000010216 calcium carbonate Nutrition 0.000 description 2
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 2
- 239000001527 calcium lactate Substances 0.000 description 2
- 235000011086 calcium lactate Nutrition 0.000 description 2
- 229960002401 calcium lactate Drugs 0.000 description 2
- 229940108928 copper Drugs 0.000 description 2
- 229940108925 copper gluconate Drugs 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 235000004626 essential fatty acids Nutrition 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 239000011790 ferrous sulphate Substances 0.000 description 2
- 235000003891 ferrous sulphate Nutrition 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000031891 intestinal absorption Effects 0.000 description 2
- 229960003284 iron Drugs 0.000 description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 2
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 2
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 2
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 2
- 230000004130 lipolysis Effects 0.000 description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 2
- 239000001095 magnesium carbonate Substances 0.000 description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 2
- 235000014380 magnesium carbonate Nutrition 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 235000011147 magnesium chloride Nutrition 0.000 description 2
- 239000001755 magnesium gluconate Substances 0.000 description 2
- 235000015778 magnesium gluconate Nutrition 0.000 description 2
- 229960003035 magnesium gluconate Drugs 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 2
- 239000011565 manganese chloride Substances 0.000 description 2
- 235000002867 manganese chloride Nutrition 0.000 description 2
- 229940099607 manganese chloride Drugs 0.000 description 2
- 239000011683 manganese gluconate Substances 0.000 description 2
- 235000014012 manganese gluconate Nutrition 0.000 description 2
- 229940072543 manganese gluconate Drugs 0.000 description 2
- OXHQNTSSPHKCPB-IYEMJOQQSA-L manganese(2+);(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Mn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OXHQNTSSPHKCPB-IYEMJOQQSA-L 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 229940111202 pepsin Drugs 0.000 description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 239000001508 potassium citrate Substances 0.000 description 2
- 229960002635 potassium citrate Drugs 0.000 description 2
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 2
- 235000011082 potassium citrates Nutrition 0.000 description 2
- 239000001230 potassium iodate Substances 0.000 description 2
- 235000006666 potassium iodate Nutrition 0.000 description 2
- JLKDVMWYMMLWTI-UHFFFAOYSA-M potassium iodate Chemical compound [K+].[O-]I(=O)=O JLKDVMWYMMLWTI-UHFFFAOYSA-M 0.000 description 2
- 229940093930 potassium iodate Drugs 0.000 description 2
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Substances [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 2
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 2
- 229910052939 potassium sulfate Inorganic materials 0.000 description 2
- 235000011151 potassium sulphates Nutrition 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 239000010499 rapseed oil Substances 0.000 description 2
- 238000005185 salting out Methods 0.000 description 2
- 235000021391 short chain fatty acids Nutrition 0.000 description 2
- 150000004666 short chain fatty acids Chemical class 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 229940083542 sodium Drugs 0.000 description 2
- 229960002901 sodium glycerophosphate Drugs 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- VPQBLCVGUWPDHV-UHFFFAOYSA-N sodium selenide Chemical compound [Na+].[Na+].[Se-2] VPQBLCVGUWPDHV-UHFFFAOYSA-N 0.000 description 2
- MSXHSNHNTORCAW-GGLLEASOSA-M sodium;(2s,3s,4s,5r,6s)-3,4,5,6-tetrahydroxyoxane-2-carboxylate Chemical compound [Na+].O[C@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O MSXHSNHNTORCAW-GGLLEASOSA-M 0.000 description 2
- REULQIKBNNDNDX-UHFFFAOYSA-M sodium;2,3-dihydroxypropyl hydrogen phosphate Chemical compound [Na+].OCC(O)COP(O)([O-])=O REULQIKBNNDNDX-UHFFFAOYSA-M 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 239000011592 zinc chloride Substances 0.000 description 2
- 235000005074 zinc chloride Nutrition 0.000 description 2
- 229960001939 zinc chloride Drugs 0.000 description 2
- 239000011670 zinc gluconate Substances 0.000 description 2
- 235000011478 zinc gluconate Nutrition 0.000 description 2
- 229960000306 zinc gluconate Drugs 0.000 description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
- 229960001763 zinc sulfate Drugs 0.000 description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 241001133760 Acoelorraphe Species 0.000 description 1
- 229930195730 Aflatoxin Natural products 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- 240000003133 Elaeis guineensis Species 0.000 description 1
- 235000001950 Elaeis guineensis Nutrition 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 230000024932 T cell mediated immunity Effects 0.000 description 1
- 101710162629 Trypsin inhibitor Proteins 0.000 description 1
- 229940122618 Trypsin inhibitor Drugs 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000005409 aflatoxin Substances 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000037180 bone health Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 208000021921 corneal disease Diseases 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000020251 goat milk Nutrition 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 239000008236 heating water Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 230000001009 osteoporotic effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229960001553 phloroglucinol Drugs 0.000 description 1
- QCDYQQDYXPDABM-UHFFFAOYSA-N phloroglucinol Chemical compound OC1=CC(O)=CC(O)=C1 QCDYQQDYXPDABM-UHFFFAOYSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention belongs to the field of formula foods for special medical purposes and in particular relates to a powder-form full-nutrient formula food and a production process thereof. The powder-form full-nutrient formula food is prepared through mixing by using high-quality protein, compound vegetable oil and carbohydrate as main raw materials and various vitamins and minerals as auxiliary materials the formula food provided by the invention not only contains a proper amount of protein, carbohydrate and fat daily needed by human bodies, but also contains minerals and vitamins needed by the human bodies through screening and proportioning of the raw materials, the daily needs of the human bodies are satisfied, the nutrient proportions are reasonable, the digestion and absorption are facilitated, the food is suitable for long-term eating, the body immunity can be enhanced, diseases can be prevented and the body health is promoted.
Description
Technical field
The invention belongs to special medicine purposes formula food field, be specifically related to the full nutritional formulas of a kind of powder-type and production technology thereof.
Background technology
At present, the full nutritional formulas of the powder-type on market is that nutrient matrix, composite mineral matter, composite vitamin are mixed and made into liquid and are then dried to powder mostly, is difficult to so technically realize, can not ensures its nutritional labeling again.Because full nutritional formulas comprehensive nutrition, complicated component, influences each other between various nutriment, antagonism mutually.Such as, the proteins and peptides composition in nutrient matrix, namely high-temperature heating causes salting-out phenomenon together with mineral matter, thus makes protein denaturation precipitation, makes creaming of emulsion, has both affected emulsion sense organ, also reduces the idiotrophic of emulsion.Simultaneously in emulsion, because moisture is large, be unfavorable for the long-term preservation of vitamin, especially the water soluble vitamin such as VC, VB1, VB6, VB12, very easily wrecks, and, in emulsion, the alkaline vitamin such as acid vitamins and VK1 such as VC reacts to each other, cannot jointly preserve for a long time, in addition, in emulsion, the mineral matter such as copper, zinc have obvious destruction to supporting one's family.
Known, collagen is a kind of high molecular functional protein, and skin can be made to keep solid and flexible.For human body, the major physiological function of collagen is bonding connective tissue.Collagen has very strong biologically active and biological function, can participate in the migration of cell, Differentiation and proliferation, makes bone, tendon, cartilage and skin have certain mechanical strength.Collagen is because its more weak antigenicity and good biocompatibility, of many uses at pharmaceutical sanitary fields such as burn, wound, cornea disease, beauty treatment, orthopedic, hard tissue repair, surface of a wound hemostasis.Containing abundant glycine, proline and hydroxyproline in collagen, also containing abundant physiologically active peptide in its hydrolysate, these characteristics make collagen and hydrolysate have good application in medical treatment, health care and beauty treatment.
Containing rich in protein and several mineral materials in fish scale, wherein organic matter accounts for 41% ~ 55%, the highest with collagen content.The discarded object total amount of the annual fish of China reaches more than 2,000,000 tons, and wherein fish scale accounts for 15%, namely 300,000 tons.If make full use of these compositions, not only can improve the added value of fish processing, reduce environmental pollution, and good economic benefit and social benefit can also be obtained.The present invention adopts pepsin to extract the protein in silver carp squama, for the utilization of silver carp processing byproduct provides reasonable approach.
In soybean protein isolate, protein content is more than 90%, and amino acid classes has nearly 20 kinds, and containing essential amino acid.It is nutritious, does not also have following nutritive value: low fat containing cholesterol simultaneously, replaces Partial Protein in meals, can not only reduce the intake of cholesterol and saturated fat with soybean protein isolate, can also reach the equilibrium of nutrition intake simultaneously.Increase calcium, soybean protein isolate can stop the loss of urine calcium, promotes bone health, reduces and suffer from osteoporotic probability.Norcholesterol, research display, daily 25g soybean protein isolate effectively can reduce the content of T-CHOL and LDL-C in blood of human body, thus reduces the risk suffered from a heart complaint.Without uncomfortable, soybean protein isolate eliminates original nutrition inhibiting factor trypsin inhibitor in soybean, does not have the reaction of the discomfort such as indigestion, gaseous distention.
Summary of the invention
Technical problem to be solved by this invention is, for the deficiencies in the prior art, formula and the production technology thereof of the full nutritional formulas of a kind of powder-type are provided, easily there is salting-out phenomenon in the protein high-temperature heating together with mineral matter solved in emulsion nutrient matrix, solve some vitamin in emulsion to react to each other in a heated condition simultaneously, lose serious problem.
For solving the problems of the technologies described above, the technical solution adopted in the present invention is: the full nutritional formulas of a kind of powder-type, comprises the following nutrient compositions of weight proportion:
Ingredient names | Content | Ingredient names | Content |
Protein | 3.2~4.5g | Biotin | 2~3μg |
Carbohydrate | 10~13g | Sodium | 70~80mg |
Fat | 2.5~3.5g | Potassium | 100~120mg |
Linoleic acid | 0.3~0.5g | Copper | 44~48μg |
Leukotrienes | 0.1~0.3g | Magnesium | 16~20mg |
Vitamin A | 45~55μg | Iron | 0.6~1mg |
Vitamin D | 0.8~1.6μg | Manganese | 120~160μg |
Vitamin E | 0.8~1.6mg | Zinc | 0.4~0.6mg |
Vitamin K1 | 5~6.6μg | Calcium | 50~66mg |
Vitamin B1 | 0.09~0.13mg | Phosphorus | 38~46mg |
Vitamin B2 | 0.09~0.13mg | Iodine | 4.5~7μg |
Vitamin B6 | 0.09~0.13mg | Chlorine | 60~90mg |
Vitamin B12 | 0.1~0.2μg | Selenium | 1.6~2.2μg |
Nicotinic acid | 0.6~0.8mg | ||
Folic acid | 20~23μg | ||
Pantothenic acid | 0.3~0.42mg | ||
Vitamin C | 20~23mg |
Further, described protein source in but be not limited to fowls egg protein, poultry milk, pigskin collagen, fish scale collagen, collagen, one or more composition in soybean protein isolate.
Further, described carbohydrate source in but one or more the composition be not limited in sucrose, maltodextrin, potato starch, ground rice.
Further, described adipose-derived in but one or more the composition be not limited in peanut oil, coconut oil, palm oil, walnut oil, rapeseed oil, soybean oil and medium chain fatty acid.
Further, described sodium mainly exists with the form of sodium chloride or gluconic acid sodium salt.The used in amounts of selected compounds is converted into the content of sodium element.
Further, described potassium exists with the form of K-IAO, potassium chloride, potassium sulfate or potassium citrate.The used in amounts of selected compounds is converted into the content of potassium element.
Further, described copper exists with the form of copper gluconate or copper sulphate.The used in amounts of selected compounds is converted into the content of copper.
Further, described magnesium exists with the form of magnesium gluconate, magnesium carbonate, magnesium sulfate or magnesium chloride.The used in amounts of selected compounds is converted into the content of magnesium elements.
Further, described iron exists with the form of iron gluconate, ferric trichloride or ferrous sulfate.The used in amounts of selected compounds is converted into the content of ferro element.
Further, described manganese exists with the form of manganese gluconate or manganese chloride.The used in amounts of selected compounds is converted into the content of manganese element.
Further, described zinc exists with the form of zinc gluconate, zinc sulfate or zinc chloride.The used in amounts of selected compounds is converted into the content of Zn-ef ficiency.
Further, described calcium exists with the form of calcium lactate, calcium carbonate, calcium phosphate, calcium gluconae or calcium chloride.The used in amounts of selected compounds is converted into the content of calcium constituent.
Further, described phosphorus exists with the form of sodium glycero-phosphate, calcium phosphate or potassium dihydrogen phosphate.The used in amounts of selected compounds is converted into the content of P elements.
Further, described iodine exists with the form of sodium iodide, KI and Potassiumiodate.The used in amounts of selected compounds is converted into the content of chlorine I.
Further, described chlorine exists with the form of sodium chloride, potassium chloride and calcium chloride.The used in amounts of selected compounds is converted into the content of chlorine element.
Further, described selenium exists with the form of Fructus Hordei Germinatus selenium or sodium selenide.The used in amounts of selected compounds is converted into the content of selenium element.
Further, the full nutritional formulas of described powder-type, comprises the following nutrient compositions of weight proportion:
Ingredient names | Content | Ingredient names | Content |
Protein | 3.8g | Biotin | 2.5μg |
Carbohydrate | 11.5g | Sodium | 75mg |
Fat | 3.0g | Potassium | 110mg |
Linoleic acid | 0.4g | Copper | 46μg |
Leukotrienes | 0.2g | Magnesium | 18mg |
Vitamin A | 50μg | Iron | 0.8mg |
Vitamin D | 1.2μg | Manganese | 140μg |
Vitamin E | 1.2mg | Zinc | 0.5mg |
Vitamin K1 | 5.8μg | Calcium | 58mg |
Vitamin B1 | 0.11mg | Phosphorus | 42mg |
Vitamin B2 | 0.11mg | Iodine | 5.7μg |
Vitamin B6 | 0.11mg | Chlorine | 75mg |
Vitamin B12 | 0.15μg | Selenium | 1.9μg |
Nicotinic acid | 0.7mg | ||
Folic acid | 21.5μg | ||
Pantothenic acid | 0.36mg | ||
Vitamin C | 21.5mg |
Further, described protein source is in milk, fish scale collagen and soybean protein isolate, and described carbohydrate source is in sucrose, potato starch and ground rice, described adipose-derived in peanut oil and soybean oil.
Further, the preparation technology of the full nutritional formulas of above-mentioned powder-type, comprises the following steps:
1) one or more composition in fowls egg protein, poultry milk, pigskin collagen, fish scale collagen, collagen, soybean protein isolate is scattered in water, is prepared into protein liquid, boils for subsequent use; By the composition dissolves of one or more in sucrose, maltodextrin, potato starch, ground rice in water, make liquid glucose, for subsequent use; Take one or more the composition in the peanut oil of said ratio, coconut oil, palm oil, walnut oil, rapeseed oil, soybean oil and medium chain fatty acid, for subsequent use; Above-mentioned protein liquid, liquid glucose and fat are mixed and homogeneous, cooling, constant volume, obtains mixed liquor; By above-mentioned mixed liquor preheating, degassed, homogeneous, sterilization, filtration, concentrated, spraying dry or freeze drying, screening, make nutrient matrix pulvis;
2) adopt ultramicro grinding to make pulvis soluble in water on sodium, potassium, copper, magnesium, iron, manganese, zinc, calcium, phosphorus, iodine, chlorine and selenium, carry out microwave or irradiation sterilization, make composite mineral powder;
3) ultramicro grinding is adopted to make pulvis soluble in water linoleic acid, leukotrienes, vitamin A, vitamin D, vitamin E, vitamin K1, vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid, pantothenic acid, vitamin C, carry out microwave or irradiation sterilization, make composite vitamin pulvis;
4) nutrient matrix pulvis, composite mineral powder and composite vitamin pulvis are mixed in gnotobasis, aseptic subpackaged, get product.
Each active ingredient and effect thereof in the present invention:
By the screening of raw material with coordinate, make in formula food of the present invention containing human body daily required appropriate protein, carbohydrate and fat, mineral matter also containing needed by human body and vitamin, meet human body daily needed for, and nutrition-allocated proportion is reasonable, is easy to absorption and digestion, long-term edible, can immunity of organisms be strengthened, prevent disease, be conducive to healthy.
In the present invention, protein is fowls egg protein, poultry milk, pigskin collagen, fish scale collagen, collagen, one or more composition in soybean protein isolate, wherein, fowls egg protein mainly refers to the protein contained in egg, duck's egg or goose egg, fowls egg protein contains abundant essential amino acid, and digestibility and absorptivity all higher.Poultry milk and livestock milk; comprise milk, goat milk, mare's milk; wherein grow containing growth in humans and metabolic necessary almost whole nutritional labelings; also be conducive to human consumption to absorb, and containing the necessary all amino acid of human body, the nutrition of human body body can be supplied; perform defencive function; control metabolic process, the invasion of defend against computer virus, useful health.Pigskin collagen is the collagen extracted from pigskin, and existing extracting method is a lot, and the present invention should adopt following method, and after pigskin is removed grease, slitting is put into water and boiled and boil, and obtains pigskin collagen.Porker collagen can slow down the aging of body cell, especially to yin asthenia generating intrinsic heat, occurs having sore throat, the edible for patients of the symptom such as low-heat is better.Fish scale collagen is the collagen extracted from fish scale, and pepsin can be adopted to extract the collagen in fish scale.In fish scale, collagen content enriches, it also can produce the Functional Polypeptides with specific function in hydrolytic process, there are some researches show, fish scale collagen significantly can reduce rat blood serum, hepatic lipid peroxidation thing MDA (MDA) content, and superoxide dismutase (SOD) vigor strengthens.Collagen is the collagen extracted in fish-skin, is a kind of native protein, containing multiple essential amino acid, has the very high property digested and assimilated, Heat stability is good.The present invention should adopt Hot water extraction to extract collagen.Soybean protein isolate is a kind of high-quality protein, has the several functions such as good dissolubility, emulsibility, water-retaining property, gelation, and the molecular characterization of protein can change with the change of its structure and composition.In the preparation process of formula food of the present invention, the spatial configuration of molecules of protein can change because of the chemistry such as constituent, heating, microwave, ultrasonic wave or physical factor, make its amino acid residue side group and polypeptide chain that certain change occur, reach the object removed peculiar smell and improve nutrient utilization, the basis not affecting protein nutritive value obtains good functional characteristic.
In the present invention, carbohydrate is one or more the composition in sucrose, maltodextrin, potato starch, ground rice.Wherein, sucrose can directly dissolve edible, can be analyzed to fructose and glucose after human consumption, through intestinal absorption, increases the synthesis of ATP in body, is conducive to the synthesis of amino acid whose vigor and protein, digests and assimilates fast.Maltodextrin is medicinal maltodextrin, has excellent emulsifiability, preferably dissolubility, stickiness appropriateness, can promote formed product, the institutional framework of adjustment product.Potato also claims potato, and potato starch infiltration rate in human body is slow, and blood sugar can not be caused to rise fast, is the desirable food therapy vegetable of diabetic; And it has good dilatancy, rehydration is good, together with other component, can improve the rheological property of product.Ground rice is the important substance forming body; Store and heat energy is provided; Maintain the energy that cerebral function is necessary; Regulate fat metabolism; Dietary fiber is provided; Save protein; Removing toxic substances; Strengthen function of intestinal canal.
In the present invention, fat is one or more in peanut oil, coconut oil, palm oil, walnut oil, rapeseed oil, soybean oil and medium chain fatty acid.Wherein, peanut oil has the effect delaying brain function aging, also has invigorating the spleen moistening lung, separates having indigestion, drives effect of dirty worm.Coconut oil is a kind of grease obtained from fresh mature coconut meat, wherein containing very a high proportion of Short-Chain Fatty Acids, and Short-Chain Fatty Acids is better water-soluble, major part just can directly by intestinal absorption without the need to the degraded through lipase, reduce engine Systemic Burden, also has antibacterial, anti-oxidant, the function such as reducing blood lipid and cholesterol simultaneously.Palm oil squeezes out from the palm fibre fruit oil palm tree, mainly containing palmitic acid (C16) and oleic acid (C18) two kinds of prevailing aliphatic acid, and easy absorption and digestion.Be rich in natural leukotrienes and vitamin A, D in walnut oil, can also blood fat be reduced, prevent artery sclerosis and atherosclerotic syndromes, hypertension, heart disease, heart failure, kidney failure and cerebral hemorrhage; Wherein, abundant omega-fatty acid can fight for cancerous swelling enzyme required in metabolism with ω-6 aliphatic acid, the cell membrane of cancer cell is become and is easy to destroy, thus the growth of inhibition tumor cell volume, reduce tumor incidence; Improve the metabolism of organism.The nutritional labelings such as unrighted acid and vitamin E such as the linoleic acid contained by rapeseed oil can be absorbed by body well, the effect there is certain softening blood vessel, delaying senility, theory of traditional Chinese medical science is thought, rape oil taste is sweet, pungent, warm in nature, can moisturize desinsection, loose erysipelas, detumescence poison.Yao Kecheng " food book on Chinese herbal medicine " also calls rape oil " apply head, order black sends out long.The stagnant blood of row, broken cold air, dispersing swelling and dissipating binds.To manage property difficulty, postpartum trusted subordinate Zhu Ji, red red heat is swollen, metal-inflicted wound bleeding ".Soybean oil contains the unrighted acids such as abundant linoleic acid, has the effect reducing blood fat and cholesterolemia, to a certain extent can angiocardiopathy preventing; Not containing carcinogen aflatoxins and cholesterol, there is protective effect to body; The leguminous phospholipid wherein contained, is of value to the development growth of nerve, blood vessel, brain.Medium chain fatty acid can be rapidly absorbed, and has good dissolubility, and research shows, medium chain fatty acid is effective as intravenous Power supply source to severe malnutrition.
Linoleic acid is generally acknowledged a kind of essential fatty acid, and must absorb from food and obtain.It has reduction blood fat, softening blood vessel, reduces blood pressure, promotes microcirculatory effect, can prevent or reduce the incidence of disease of cardiovascular disease, particularly very favourable to the control of hypertension, high fat of blood, angina pectoris, coronary heart disease, atherosclerotic, senile obesity etc., the deposition preventing human serum cholesterol at vascular wall can be played, have the good reputation of " blood vessel street cleaner ".It in vivo metabolism can produce again ω-6 aliphatic acid human body being had to important physiological function, being the precursor showing special bioactive compound eicosanoid, is affect blood pressure, vascular reactivity, blood coagulation and immune Adipose hormone; There is participation lipolysis and metabolism, strengthen body immunity, promote the effects such as the metabolism of bone tissue.Therefore, add appropriate linoleic acid in formula food of the present invention, by the synergy with other component, the raising to immunity of organisms, metabolism of bone tissue and lipolysis and metabolic function can be realized preferably.Leukotrienes is also a kind of essential fatty acid, the same with linoleic acid, also must be obtained by picked-up in food.Current research shows, human body lacks leukotrienes, may cause the generation of a series of disease, such as brain function is abnormal, skin damage, extremity numbness or difficulty in walking etc., if can not supplement in daily bread, to the normal operation of body function with recover will be all disadvantageous.Leukotrienes in vivo metabolism can produce again omega-fatty acid human body being had to important physiological function.Meanwhile, linoleic acid plus linolenic acid is easily oxidized in atmosphere, and preparation packaging and transportation all need strictly to control air content, and, also need the ratio matching both, make it to be conducive to diseases prevention, do not produce other harmful effect again simultaneously, body equilibrium is absorbed.
In the present invention, various composition or raw material all belong to existing product, or commercially can buy and obtain, or can prepare according to prior art.
The full nutritional formulas of powder-type of the present invention can maintain the balance of health nutriment, digest and assimilate fast, make various nutritional labeling produce synergy in vivo, assimilated fully, and reach control energy intake, effect such as control body weight and nutrition and health care etc. simultaneously.
Detailed description of the invention
In order to illustrate further in more detail instead of limit the present invention, provide the following example.
Embodiment 1
The full nutritional formulas of a kind of powder-type of the present invention, comprises the following nutrient compositions of weight proportion:
Ingredient names | Content | Ingredient names | Content |
Protein | 4.5g | Biotin | 3μg |
Carbohydrate | 10g | Sodium | 70mg |
Fat | 3.5g | Potassium | 100mg |
Linoleic acid | 0.3g | Copper | 44μg |
Leukotrienes | 0.2g | Magnesium | 18mg |
Vitamin A | 55μg | Iron | 0.6mg |
Vitamin D | 1.2μg | Manganese | 130μg |
Vitamin E | 0.8mg | Zinc | 0.4mg |
Vitamin K1 | 6.0μg | Calcium | 58mg |
Vitamin B1 | 0.09mg | Phosphorus | 40mg |
Vitamin B2 | 0.13mg | Iodine | 5.0μg |
Vitamin B6 | 0.10mg | Chlorine | 60mg |
Vitamin B12 | 0.1μg | Selenium | 2.0μg |
Nicotinic acid | 0.6mg | ||
Folic acid | 20μg | ||
Pantothenic acid | 0.40mg | ||
Vitamin C | 20mg |
, wherein, described protein source is in milk, pigskin collagen and soybean protein isolate, and described carbohydrate source is in sucrose, maltodextrin and ground rice, described adipose-derived in soybean oil and peanut oil.
Embodiment 2
The full nutritional formulas of a kind of powder-type of the present invention, comprises the following nutrient compositions of weight proportion:
Ingredient names | Content | Ingredient names | Content |
Protein | 3.8g | Biotin | 2μg |
Carbohydrate | 11g | Sodium | 75mg |
Fat | 3.0g | Potassium | 120mg |
Linoleic acid | 0.4g | Copper | 45μg |
Leukotrienes | 0.1g | Magnesium | 16mg |
Vitamin A | 48μg | Iron | 1.0mg |
Vitamin D | 0.8μg | Manganese | 120μg |
Vitamin E | 1.0mg | Zinc | 0.6mg |
Vitamin K1 | 5.0μg | Calcium | 50mg |
Vitamin B1 | 0.10mg | Phosphorus | 38mg |
Vitamin B2 | 0.10mg | Iodine | 4.5μg |
Vitamin B6 | 0.13mg | Chlorine | 70mg |
Vitamin B12 | 0.15μg | Selenium | 1.6μg |
Nicotinic acid | 0.7mg | ||
Folic acid | 22μg | ||
Pantothenic acid | 0.35mg | ||
Vitamin C | 21mg |
, wherein, described protein source is in Chicken Albumin, collagen and soybean protein isolate, and described carbohydrate source is in sucrose, maltodextrin and potato starch, described adipose-derived in coconut oil.
Embodiment 3
The full nutritional formulas of a kind of powder-type of the present invention, comprises the following nutrient compositions of weight proportion:
Ingredient names | Content | Ingredient names | Content |
Protein | 3.2g | Biotin | 3μg |
Carbohydrate | 13g | Sodium | 80mg |
Fat | 2.5g | Potassium | 100mg |
Linoleic acid | 0.5g | Copper | 48μg |
Leukotrienes | 0.1g | Magnesium | 16mg |
Vitamin A | 45μg | Iron | 1mg |
Vitamin D | 1.6μg | Manganese | 120μg |
Vitamin E | 0.8mg | Zinc | 0.6mg |
Vitamin K1 | 6.6μg | Calcium | 50mg |
Vitamin B1 | 0.13mg | Phosphorus | 46mg |
Vitamin B2 | 0.09mg | Iodine | 7μg |
Vitamin B6 | 0.09mg | Chlorine | 90mg |
Vitamin B12 | 0.20μg | Selenium | 2.2μg |
Nicotinic acid | 0.8mg | ||
Folic acid | 23μg | ||
Pantothenic acid | 0.30mg | ||
Vitamin C | 20mg |
, wherein, described protein source is in milk, collagen and soybean protein isolate, and described carbohydrate source is in maltodextrin, potato starch and ground rice, described adipose-derived in walnut oil and peanut oil.
Embodiment 4
The full nutritional formulas of a kind of powder-type of the present invention, comprises the following nutrient compositions of weight proportion:
Ingredient names | Content | Ingredient names | Content |
Protein | 4.0g | Biotin | 2.5μg |
Carbohydrate | 12.5g | Sodium | 75mg |
Fat | 2.8g | Potassium | 100mg |
Linoleic acid | 0.35g | Copper | 44μg |
Leukotrienes | 0.23g | Magnesium | 19mg |
Vitamin A | 50μg | Iron | 0.6mg |
Vitamin D | 1.4μg | Manganese | 140μg |
Vitamin E | 1.0mg | Zinc | 0.6mg |
Vitamin K1 | 5.2μg | Calcium | 66mg |
Vitamin B1 | 0.09mg | Phosphorus | 40mg |
Vitamin B2 | 0.12mg | Iodine | 5.5μg |
Vitamin B6 | 0.10mg | Chlorine | 75mg |
Vitamin B12 | 0.15μg | Selenium | 1.6μg |
Nicotinic acid | 0.7mg | ||
Folic acid | 21.5μg | ||
Pantothenic acid | 0.35mg | ||
Vitamin C | 23mg |
, wherein, described protein source is in collagen, and described carbohydrate source is in potato starch, described adipose-derived in palm oil.
Embodiment 5
The full nutritional formulas of a kind of powder-type of the present invention, comprises the following nutrient compositions of weight proportion:
Ingredient names | Content | Ingredient names | Content |
Protein | 3.8g | Biotin | 2.5μg |
Carbohydrate | 11.5g | Sodium | 75mg |
Fat | 3.0g | Potassium | 110mg |
Linoleic acid | 0.4g | Copper | 46μg |
Leukotrienes | 0.2g | Magnesium | 18mg |
Vitamin A | 50μg | Iron | 0.8mg |
Vitamin D | 1.2μg | Manganese | 140μg |
Vitamin E | 1.2mg | Zinc | 0.5mg |
Vitamin K1 | 5.8μg | Calcium | 58mg |
Vitamin B1 | 0.11mg | Phosphorus | 42mg |
Vitamin B2 | 0.11mg | Iodine | 5.7μg |
Vitamin B6 | 0.11mg | Chlorine | 75mg |
Vitamin B12 | 0.15μg | Selenium | 1.9μg |
Nicotinic acid | 0.7mg | ||
Folic acid | 21.5μg | ||
Pantothenic acid | 0.36mg | ||
Vitamin C | 21.5mg |
, wherein, described protein source is in milk, fish scale collagen and soybean protein isolate, and described carbohydrate source is in sucrose, potato starch and ground rice, described adipose-derived in peanut oil and soybean oil.Embodiment 6
The full nutritional formulas of a kind of powder-type of the present invention, comprises the following nutrient compositions of weight proportion:
Ingredient names | Content | Ingredient names | Content |
Protein | 3.5g | Biotin | 2μg |
Carbohydrate | 12g | Sodium | 75mg |
Fat | 2.5g | Potassium | 110mg |
Linoleic acid | 0.5g | Copper | 46μg |
Leukotrienes | 0.1g | Magnesium | 20mg |
Vitamin A | 55μg | Iron | 1.0mg |
Vitamin D | 0.8μg | Manganese | 150μg |
Vitamin E | 1.2mg | Zinc | 0.5mg |
Vitamin K1 | 6.2μg | Calcium | 60mg |
Vitamin B1 | 0.12mg | Phosphorus | 42mg |
Vitamin B2 | 0.093mg | Iodine | 6.5μg |
Vitamin B6 | 0.113mg | Chlorine | 80mg |
Vitamin B12 | 0.15μg | Selenium | 2.0μg |
Nicotinic acid | 0.7mg | ||
Folic acid | 21.5μg | ||
Pantothenic acid | 0.38mg | ||
Vitamin C | 20mg |
, wherein, described protein source is in Chicken Albumin, pigskin collagen and soybean protein isolate, and described carbohydrate source is in sucrose and maltodextrin, described adipose-derived in soybean oil and rapeseed oil.
Embodiment 7
The full nutritional formulas of a kind of powder-type of the present invention, comprises the following nutrient compositions of weight proportion:
Ingredient names | Content | Ingredient names | Content |
Protein | 3.2g | Biotin | 2μg |
Carbohydrate | 13g | Sodium | 70mg |
Fat | 2.5g | Potassium | 110mg |
Linoleic acid | 0.3g | Copper | 48μg |
Leukotrienes | 0.2g | Magnesium | 16mg |
Vitamin A | 54μg | Iron | 1mg |
Vitamin D | 0.9μg | Manganese | 120μg |
Vitamin E | 1.2mg | Zinc | 0.5mg |
Vitamin K1 | 5.4μg | Calcium | 58mg |
Vitamin B1 | 0.12mg | Phosphorus | 45mg |
Vitamin B2 | 0.09mg | Iodine | 6μg |
Vitamin B6 | 0.10mg | Chlorine | 70mg |
Vitamin B12 | 0.12μg | Selenium | 2.0μg |
Nicotinic acid | 0.8mg | ||
Folic acid | 21μg | ||
Pantothenic acid | 0.3mg | ||
Vitamin C | 20mg |
, wherein, described protein source is in soybean protein isolate, and described carbohydrate source is in maltodextrin, described adipose-derived in medium chain fatty acid.
Embodiment 8
The full nutritional formulas of a kind of powder-type of the present invention, comprises the following nutrient compositions of weight proportion:
Ingredient names | Content | Ingredient names | Content |
Protein | 4.5g | Biotin | 2μg |
Carbohydrate | 12g | Sodium | 75mg |
Fat | 2.5g | Potassium | 105mg |
Linoleic acid | 0.4g | Copper | 45μg |
Leukotrienes | 0.25g | Magnesium | 18mg |
Vitamin A | 48μg | Iron | 0.8mg |
Vitamin D | 1.4μg | Manganese | 120μg |
Vitamin E | 1.0mg | Zinc | 0.6mg |
Vitamin K1 | 6.2μg | Calcium | 66mg |
Vitamin B1 | 0.12mg | Phosphorus | 38mg |
Vitamin B2 | 0.10mg | Iodine | 5.0μg |
Vitamin B6 | 0.09mg | Chlorine | 85mg |
Vitamin B12 | 0.15μg | Selenium | 1.8μg |
Nicotinic acid | 0.75mg | ||
Folic acid | 20μg | ||
Pantothenic acid | 0.40mg | ||
Vitamin C | 20mg |
, wherein, described protein source is in Chicken Albumin, fish scale collagen and soybean protein isolate, and described carbohydrate source is in maltodextrin and ground rice, described adipose-derived in soybean oil and peanut oil.
Embodiment 9
The full nutritional formulas of a kind of powder-type of the present invention, comprises the following nutrient compositions of weight proportion:
Ingredient names | Content | Ingredient names | Content |
Protein | 4.1g | Vitamin C | 22mg |
Carbohydrate | 10g | Sodium | 75mg |
Fat | 3.5g | Potassium | 110mg |
Linoleic acid | 0.3g | Copper | 46μg |
Leukotrienes | 0.2g | Magnesium | 18mg |
Vitamin A | 50μg | Iron | 0.8mg |
Vitamin D | 1.6μg | Manganese | 140μg |
Vitamin E | 1.2mg | Zinc | 0.5mg |
Vitamin K1 | 6.6μg | Calcium | 58mg |
Vitamin B1 | 0.12mg | Phosphorus | 42mg |
Vitamin B2 | 0.09mg | Iodine | 5.2μg |
Vitamin B6 | 0.103mg | Chlorine | 75mg |
Vitamin B12 | 0.14μg | Selenium | 1.9μg |
Nicotinic acid | 0.8mg | ||
Folic acid | 21μg | ||
Pantothenic acid | 0.36mg | ||
Biotin | 2.6μg |
, wherein, described protein source is in fish scale collagen and soybean protein isolate, and described carbohydrate source is in potato starch, described adipose-derived in rapeseed oil.
In above-described embodiment 1 ~ 9, described sodium mainly exists with the form of sodium chloride or gluconic acid sodium salt.The used in amounts of selected compounds is converted into the content of sodium element.Described potassium exists with the form of K-IAO, potassium chloride, potassium sulfate or potassium citrate.The used in amounts of selected compounds is converted into the content of potassium element.Described copper exists with the form of copper gluconate or copper sulphate.The used in amounts of selected compounds is converted into the content of copper.Described magnesium exists with the form of magnesium gluconate, magnesium carbonate, magnesium sulfate or magnesium chloride.The used in amounts of selected compounds is converted into the content of magnesium elements.Described iron exists with the form of iron gluconate, ferric trichloride or ferrous sulfate.The used in amounts of selected compounds is converted into the content of ferro element.Described manganese exists with the form of manganese gluconate or manganese chloride.The used in amounts of selected compounds is converted into the content of manganese element.Described zinc exists with the form of zinc gluconate, zinc sulfate or zinc chloride.The used in amounts of selected compounds is converted into the content of Zn-ef ficiency.Described calcium exists with the form of calcium lactate, calcium carbonate, calcium phosphate, calcium gluconae or calcium chloride.The used in amounts of selected compounds is converted into the content of calcium constituent.Described phosphorus exists with the form of sodium glycero-phosphate, calcium phosphate or potassium dihydrogen phosphate.The used in amounts of selected compounds is converted into the content of P elements.Described iodine exists with the form of sodium iodide, KI and Potassiumiodate.The used in amounts of selected compounds is converted into the content of chlorine I.Described chlorine exists with the form of sodium chloride, potassium chloride and calcium chloride.The used in amounts of selected compounds is converted into the content of chlorine element.Described selenium exists with the form of Fructus Hordei Germinatus selenium or sodium selenide.The used in amounts of selected compounds is converted into the content of selenium element.
Additionally provide the preparation technology of the full nutritional formulas of above-mentioned powder-type in the present invention, comprise the following steps:
1) one or more composition in fowls egg protein, poultry milk, pigskin collagen, fish scale collagen, collagen, soybean protein isolate is scattered in water, is prepared into protein liquid, boils for subsequent use; By the composition dissolves of one or more in sucrose, maltodextrin, potato starch, ground rice in water, make liquid glucose, for subsequent use; Take one or more the composition in the peanut oil of said ratio, coconut oil, palm oil, walnut oil, rapeseed oil, soybean oil and medium chain fatty acid, for subsequent use; Above-mentioned protein liquid, liquid glucose and fat are mixed and homogeneous, cooling, constant volume, obtains mixed liquor; By above-mentioned mixed liquor preheating, degassed, homogeneous, sterilization, filtration, concentrated, spraying dry or freeze drying, screening, make nutrient matrix pulvis;
2) adopt ultramicro grinding to make pulvis soluble in water on sodium, potassium, copper, magnesium, iron, manganese, zinc, calcium, phosphorus, iodine, chlorine and selenium, carry out microwave or irradiation sterilization, make composite mineral powder;
3) ultramicro grinding is adopted to make pulvis soluble in water linoleic acid, leukotrienes, vitamin A, vitamin D, vitamin E, vitamin K1, vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid, pantothenic acid, vitamin C, carry out microwave or irradiation sterilization, make composite vitamin pulvis;
4) nutrient matrix pulvis, composite mineral powder and composite vitamin pulvis are mixed in gnotobasis, aseptic subpackaged, get product.
The full nutritional formulas of powder-type provided by the invention is tested the impact of mouse intestinal function:
Get the embodiment of the present invention 1 ~ 9 gained formula food to test, establish blank group simultaneously, blank group gavage physiological saline.
SPF level BALB/C mice, male, body weight 25 ~ 30g, often organizes 10.According to 0.035g/10g dosage gavage every day mouse, continuous 30 days.Feed to cage single during mice lavage, measure it every day and take in appetite, within every 3 days, claim 1 body weight, increase, the body weight of final calculating each group of food ration increase, calculate food exchange share.Food utilization=body weight increases (g) ÷ food weight (g) × 100%.
The impact of the full nutritional formulas of powder-type on Mouse Weight the results are shown in Table 1, the results are shown in Table 2 to the impact of mouse chow usage factor.
The full nutritional formulas of table 1 powder-type is on the impact of Mouse Weight
Group | First body weight/g | End-body weight/g | Weightening finish/g |
Embodiment 1 | 25.9 | 43.4 | 17.5 |
Embodiment 2 | 27.1 | 45.0 | 17.9 |
Embodiment 3 | 27.1 | 44.4 | 17.3 |
Embodiment 4 | 28.3 | 46.4 | 18.1 |
Embodiment 5 | 26.4 | 45.0 | 18.6 |
Embodiment 6 | 25.7 | 42.8 | 17.1 |
Embodiment 7 | 26.9 | 43.6 | 16.7 |
Embodiment 8 | 26.3 | 44.0 | 17.7 |
Embodiment 9 | 26.1 | 43.0 | 16.9 |
Control group | 28.3 | 42.0 | 13.7 |
As shown in Table 1, compare with control group, the body weight of embodiment 1 ~ 9 group of mouse increases there was no significant difference (P > 0.05).Visible, said preparation has no obvious impact to Mouse Weight growth, can maintain the normal physiological function of mouse.
The full nutritional formulas of table 2 powder-type is on the impact of mouse chow usage factor
Group | Food exchange share/% |
Embodiment 1 | 4.81 |
Embodiment 2 | 4.73 |
Embodiment 3 | 4.61 |
Embodiment 4 | 4.62 |
Embodiment 5 | 4.96 |
Embodiment 6 | 4.75 |
Embodiment 7 | 4.51 |
Embodiment 8 | 4.80 |
Embodiment 9 | 4.66 |
Control group | 3.71 |
As shown in Table 2, the full nutritional formulas of powder-type provided by the invention can significantly improve mouse chow usage factor, is conducive to digesting and assimilating.
Get the embodiment of the present invention 1 ~ 9 to test, according to 0.035g/10g dosage gavage every day mouse, continuous 7 days.Can't help water 24h to fasting in the 6th of nutrient solution the day, after giving nutrient solution for the last time, 1h gives 50g/L D-xylose liquid 20mL/kg, and 1h posterior orbit gets blood, separation of serum.Take out 40L serum and add 4ml developer (get phloroglucin 0.5g and add 100g glacial acetic acid and 6ml concentrated hydrochloric acid), mixing, 100 DEG C of heating water bath 10min, flowing water is cooled to room temperature, use 554nm wavelength, add developer pipe with distilled water and reset, measure the trap of each pipe.The full nutritional formulas of powder-type the results are shown in Table 3 to the impact that mouse small intestine absorbs.
The impact that the full nutritional formulas of table 3 powder-type absorbs mouse small intestine
Group | Number of animals/only | Trap |
Embodiment 1 | 10 | 0.81 |
Embodiment 2 | 10 | 0.81 |
Embodiment 3 | 10 | 0.80 |
Embodiment 4 | 10 | 0.80 |
Embodiment 5 | 10 | 0.90 |
Embodiment 6 | 10 | 0.83 |
Embodiment 7 | 10 | 0.69 |
Embodiment 8 | 10 | 0.85 |
Embodiment 9 | 10 | 0.79 |
Control group | 10 | 0.54 |
As shown in Table 3, the full nutritional formulas of powder-type provided by the invention has obvious promotion functions to digesting and assimilating of mouse.
The full nutritional formulas of powder-type provided by the invention is on the impact of immune function of mice:
Adopt mouse spleen lymphocyte transformation experiment, with reference to the method for the Ministry of Public Health " health food inspection and assessment specification " (version in 2003).The impact of the full nutritional formulas of powder-type on mice spleen lymphocytes proliferation ability the results are shown in Table 4.
Adopt mouse carbon particle clearance test, with reference to the method for the Ministry of Public Health " health food inspection and assessment specification " (version in 2003).The impact of the full nutritional formulas of powder-type on mouse mouse monocytes/macrophages function the results are shown in Table 5.
The full nutritional formulas of table 4 powder-type is on the impact of mice spleen lymphocytes proliferation ability
Group | Number of animals/only | OD value |
Embodiment 1 | 10 | 0.190 |
Embodiment 2 | 10 | 0.187 |
Embodiment 3 | 10 | 0.185 |
Embodiment 4 | 10 | 0.181 |
Embodiment 5 | 10 | 0.214 |
Embodiment 6 | 10 | 0.196 |
Embodiment 7 | 10 | 0.180 |
Embodiment 8 | 10 | 0.203 |
Embodiment 9 | 10 | 0.192 |
Control group | 10 | 0.112 |
As shown in Table 4, compared with control group, the full nutritional formulas of powder-type provided by the invention can significantly improve spleen lymphocyte proliferation rate, illustrate that the full nutritional formulas of powder-type provided by the invention obviously can strengthen the Cell-mediated Immunity of body, improve the suppressed state of human body immune function, strengthen the specific immune function of body.
The full nutritional formulas of table 5 powder-type is on the impact of mouse monokaryon-macrophage function
Group | Number of animals/only | Phagocytic index |
Embodiment 1 | 10 | 6.82 |
Embodiment 2 | 10 | 6.73 |
Embodiment 3 | 10 | 6.70 |
Embodiment 4 | 10 | 6.48 |
Embodiment 5 | 10 | 7.29 |
Embodiment 6 | 10 | 7.01 |
Embodiment 7 | 10 | 6.27 |
Embodiment 8 | 10 | 6.98 |
Embodiment 9 | 10 | 6.59 |
Control group | 10 | 4.22 |
As shown in Table 5, compared with control group, the full nutritional formulas of powder-type provided by the invention can significantly improve the phagocytic index of monocytes/macrophages, illustrate that the full nutritional formulas of powder-type provided by the invention may have the effect promoting monocytes/macrophages phagocytic function, strengthen the non-specific immune function of body.
As can be seen from above-described embodiment 1 ~ 9 and experimental result, the combination property of embodiment 5 gained formula food is obviously better than other embodiment, comprise food exchange share, digest and assimilate performance, spleen lymphocyte proliferation ability and monocytes/macrophages function, next is embodiment 6 and embodiment 8, therefrom can find out, different material combination and composition proportion, the impact having highly significant is embodied on the final performance of formula food of the present invention, this and raw materials used self performance, the change of raw material character in preparation technology and have inseparable relation with the mutual cooperation effect of other component.
Claims (7)
1. the full nutritional formulas of powder-type, is characterized in that: the full nutritional formulas of described powder-type comprises the following nutrient compositions of weight proportion:
。
2. the full nutritional formulas of powder-type as claimed in claim 1, is characterized in that: described protein source one or more composition in fowls egg protein, poultry milk, pigskin collagen, fish scale collagen, collagen, soybean protein isolate.
3. the full nutritional formulas of powder-type as claimed in claim 1, is characterized in that: one or more the composition of described carbohydrate source in sucrose, maltodextrin, potato starch, ground rice.
4. the full nutritional formulas of powder-type as claimed in claim 1, is characterized in that: described adipose-derived one or more composition in peanut oil, coconut oil, palm oil, walnut oil, rapeseed oil, soybean oil and medium chain fatty acid.
5. the full nutritional formulas of powder-type as claimed in claim 1, is characterized in that: the full nutritional formulas of described powder-type comprises the following nutrient compositions of weight proportion:
。
6. the full nutritional formulas of powder-type as claimed in claim 5, it is characterized in that: described protein source is in milk, fish scale collagen and soybean protein isolate, described carbohydrate source is in sucrose, potato starch and ground rice, described adipose-derived in peanut oil and soybean oil.
7. a preparation technology for the full nutritional formulas of powder-type, is characterized in that: it comprises the following steps:
One or more composition in fowls egg protein, poultry milk, pigskin collagen, fish scale collagen, collagen, soybean protein isolate is scattered in water, is prepared into protein liquid, boils for subsequent use; By the composition dissolves of one or more in sucrose, maltodextrin, potato starch, ground rice in water, make liquid glucose, for subsequent use; Take one or more the composition in the peanut oil of said ratio, coconut oil, palm oil, walnut oil, rapeseed oil, soybean oil and medium chain fatty acid, for subsequent use; Above-mentioned protein liquid, liquid glucose and fat are mixed and homogeneous, cooling, constant volume, obtains mixed liquor; By above-mentioned mixed liquor preheating, degassed, homogeneous, sterilization, filtration, concentrated, spraying dry or freeze drying, screening, make nutrient matrix pulvis;
2) adopt ultramicro grinding to make pulvis soluble in water on sodium, potassium, copper, magnesium, iron, manganese, zinc, calcium, phosphorus, iodine, chlorine and selenium, carry out microwave or irradiation sterilization, make composite mineral powder;
3) ultramicro grinding is adopted to make pulvis soluble in water linoleic acid, leukotrienes, vitamin A, vitamin D, vitamin E, vitamin K1, vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid, pantothenic acid, vitamin C, carry out microwave or irradiation sterilization, make composite vitamin pulvis;
4) nutrient matrix pulvis, composite mineral powder and composite vitamin pulvis are mixed in gnotobasis, aseptic subpackaged, get product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510273213.6A CN104839718A (en) | 2015-05-26 | 2015-05-26 | Powder-form full-nutrient formula food and production process thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510273213.6A CN104839718A (en) | 2015-05-26 | 2015-05-26 | Powder-form full-nutrient formula food and production process thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104839718A true CN104839718A (en) | 2015-08-19 |
Family
ID=53840013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510273213.6A Pending CN104839718A (en) | 2015-05-26 | 2015-05-26 | Powder-form full-nutrient formula food and production process thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104839718A (en) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105285727A (en) * | 2015-09-22 | 2016-02-03 | 南阳市汇博生物技术有限公司 | Full nutrient emulsion type formula food for obese people after fat loss surgery and preparation method of full nutrient emulsion type formula food |
CN105410918A (en) * | 2015-12-11 | 2016-03-23 | 无锡超科食品科技有限公司 | Total nutrient formula powder and preparation method thereof |
CN107536021A (en) * | 2016-06-29 | 2018-01-05 | 玛士撒拉(上海)医疗科技有限公司 | A kind of fortification albumen composite powder and preparation method thereof |
CN107712857A (en) * | 2017-10-18 | 2018-02-23 | 北京逯博士行为医学科技研究院有限公司 | A kind of Chinese meal bag and preparation method thereof |
CN108157953A (en) * | 2018-01-19 | 2018-06-15 | 山东理工大学 | A kind of full nutrition formula food and preparation method thereof |
CN108294302A (en) * | 2018-01-30 | 2018-07-20 | 贵州中科金玖生物技术有限公司 | A kind of full nutrient formulation powder, preparation method and its product |
CN108378377A (en) * | 2018-05-08 | 2018-08-10 | 山东理工大学 | The preparation method and applications of cervical carcinoma full nutrition formula food |
CN108433109A (en) * | 2018-03-12 | 2018-08-24 | 云南雪域印象生物科技有限公司 | Nutrient powder |
CN108618127A (en) * | 2018-04-16 | 2018-10-09 | 朱娜玲 | A kind of full nutritional factors oral solution and preparation method thereof |
CN108741022A (en) * | 2018-05-15 | 2018-11-06 | 烟台双塔食品股份有限公司 | A kind of full nutrition formula food and preparation method thereof |
CN108741086A (en) * | 2018-06-07 | 2018-11-06 | 山东理工大学 | A kind of sports tonica and preparation method thereof suitable for long-term body-building |
CN108936602A (en) * | 2018-06-07 | 2018-12-07 | 山东理工大学 | A kind of double protein sports tonica and preparation method thereof |
CN108968046A (en) * | 2018-07-25 | 2018-12-11 | 哈尔滨拜仑斯特临床营养有限公司 | A kind of special medicine purposes full nutrition formula food and preparation method thereof |
CN109077304A (en) * | 2018-08-20 | 2018-12-25 | 中南林业科技大学 | Pine needle ferment, preparation method and decompression full nutrition formula food and eating method |
CN110419736A (en) * | 2019-04-25 | 2019-11-08 | 河北康睿达脂质有限公司 | A kind of middle backbone lipid composition preparation method of mammary gland disease nutrition treatment |
CN111264871A (en) * | 2020-03-31 | 2020-06-12 | 中国农业大学 | Quinoa protein-based total-nutrient formula food for allergic people |
CN107467193B (en) * | 2017-09-07 | 2020-12-15 | 黑龙江飞鹤乳业有限公司 | A powder food based on goat milk for special medical use and its preparation method |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001097633A2 (en) * | 2000-06-19 | 2001-12-27 | General Mills, Inc. | Nutrient clusters for food products and methods of preparation |
CN101313704A (en) * | 2008-07-09 | 2008-12-03 | 内蒙古蒙牛乳业(集团)股份有限公司 | Liquid milk for baby of birth time to 12 months ages and method using online addition technique |
CN101804196A (en) * | 2010-04-09 | 2010-08-18 | 卜汉蒙 | Soybean-based whole protein type enteral nutrition powder and preparation method thereof |
CN101984836A (en) * | 2010-09-06 | 2011-03-16 | 浙江贝因美科工贸股份有限公司 | Method for producing novel infant formula milk powder |
CN102223812A (en) * | 2008-12-08 | 2011-10-19 | 雀巢产品技术援助有限公司 | Modulation of infant fat mass |
-
2015
- 2015-05-26 CN CN201510273213.6A patent/CN104839718A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001097633A2 (en) * | 2000-06-19 | 2001-12-27 | General Mills, Inc. | Nutrient clusters for food products and methods of preparation |
CN101313704A (en) * | 2008-07-09 | 2008-12-03 | 内蒙古蒙牛乳业(集团)股份有限公司 | Liquid milk for baby of birth time to 12 months ages and method using online addition technique |
CN102223812A (en) * | 2008-12-08 | 2011-10-19 | 雀巢产品技术援助有限公司 | Modulation of infant fat mass |
CN101804196A (en) * | 2010-04-09 | 2010-08-18 | 卜汉蒙 | Soybean-based whole protein type enteral nutrition powder and preparation method thereof |
CN101984836A (en) * | 2010-09-06 | 2011-03-16 | 浙江贝因美科工贸股份有限公司 | Method for producing novel infant formula milk powder |
Non-Patent Citations (1)
Title |
---|
国家食品安全风险评估中心等: "《食品安全国家标准汇编 食品产品 特殊膳食用食品 食品生产经营规范 食品相关产品》", 31 March 2014 * |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105285727A (en) * | 2015-09-22 | 2016-02-03 | 南阳市汇博生物技术有限公司 | Full nutrient emulsion type formula food for obese people after fat loss surgery and preparation method of full nutrient emulsion type formula food |
CN105410918A (en) * | 2015-12-11 | 2016-03-23 | 无锡超科食品科技有限公司 | Total nutrient formula powder and preparation method thereof |
CN107536021A (en) * | 2016-06-29 | 2018-01-05 | 玛士撒拉(上海)医疗科技有限公司 | A kind of fortification albumen composite powder and preparation method thereof |
CN107467193B (en) * | 2017-09-07 | 2020-12-15 | 黑龙江飞鹤乳业有限公司 | A powder food based on goat milk for special medical use and its preparation method |
CN107712857A (en) * | 2017-10-18 | 2018-02-23 | 北京逯博士行为医学科技研究院有限公司 | A kind of Chinese meal bag and preparation method thereof |
CN108157953A (en) * | 2018-01-19 | 2018-06-15 | 山东理工大学 | A kind of full nutrition formula food and preparation method thereof |
CN108294302A (en) * | 2018-01-30 | 2018-07-20 | 贵州中科金玖生物技术有限公司 | A kind of full nutrient formulation powder, preparation method and its product |
CN108433109A (en) * | 2018-03-12 | 2018-08-24 | 云南雪域印象生物科技有限公司 | Nutrient powder |
CN108618127A (en) * | 2018-04-16 | 2018-10-09 | 朱娜玲 | A kind of full nutritional factors oral solution and preparation method thereof |
CN108378377A (en) * | 2018-05-08 | 2018-08-10 | 山东理工大学 | The preparation method and applications of cervical carcinoma full nutrition formula food |
CN108741022A (en) * | 2018-05-15 | 2018-11-06 | 烟台双塔食品股份有限公司 | A kind of full nutrition formula food and preparation method thereof |
CN108741086A (en) * | 2018-06-07 | 2018-11-06 | 山东理工大学 | A kind of sports tonica and preparation method thereof suitable for long-term body-building |
CN108936602A (en) * | 2018-06-07 | 2018-12-07 | 山东理工大学 | A kind of double protein sports tonica and preparation method thereof |
CN108968046A (en) * | 2018-07-25 | 2018-12-11 | 哈尔滨拜仑斯特临床营养有限公司 | A kind of special medicine purposes full nutrition formula food and preparation method thereof |
CN109077304A (en) * | 2018-08-20 | 2018-12-25 | 中南林业科技大学 | Pine needle ferment, preparation method and decompression full nutrition formula food and eating method |
CN110419736A (en) * | 2019-04-25 | 2019-11-08 | 河北康睿达脂质有限公司 | A kind of middle backbone lipid composition preparation method of mammary gland disease nutrition treatment |
CN110419736B (en) * | 2019-04-25 | 2022-07-05 | 河北康睿达脂质有限公司 | Preparation method of medium-long chain structure lipid composition for nutritional treatment of breast diseases |
CN111264871A (en) * | 2020-03-31 | 2020-06-12 | 中国农业大学 | Quinoa protein-based total-nutrient formula food for allergic people |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104839718A (en) | Powder-form full-nutrient formula food and production process thereof | |
CN104855845A (en) | Natto nutritional health food | |
CN105296584A (en) | Preparation method of marine biological health care peptide preparation | |
CN104824655A (en) | Basic full-nutritional special medical formula food and preparation technique thereof | |
CN1742927A (en) | Medicinal tablet made from fruit of Chinese wolfberry and spica Mori and its preparing process | |
CN104855994A (en) | Non-full nutritional formula food for patients with nephropathy | |
CN104839707A (en) | Yin deficiency physique non-total nutrient formula food | |
CN104855997A (en) | Non-whole nutrient formula food for osteoporosis | |
CN105942297A (en) | Sea cucumber powder and preparation method thereof | |
CN115399449A (en) | Preparation method of bone nutrition snowflake tablets | |
CN104872638A (en) | Non-total nutrient formula food for constipation patients | |
CN104799281A (en) | Method for producing compound peanut milk suitable for old people | |
CN104839695A (en) | Inflammatory bowel disease non-total nutrient formula food | |
CN104839698A (en) | Cardiovascular disease non-total nutrient formula food | |
CN110214942A (en) | A kind of hyperthyroidism tailored version Nutrition formula and preparation method thereof | |
CN108541912A (en) | A kind of anti-oxidant blood-fat reducing composition and its preparation method and application | |
CN104855963A (en) | Non-full nutritional formula food for delivery women in postpartum recuperation | |
CN112205557A (en) | Hypolipidemic solid food beverage and preparation method thereof | |
JP5156330B2 (en) | Adipose tissue weight reducing agent | |
CN104839704A (en) | Yang invigorating non-total nutrient formula food | |
CN104855969A (en) | Non-whole nutrient formula food for liver diseases | |
CN108095075A (en) | Miscarriage women tailored version clinical nutrition formula and preparation method thereof | |
CN102511882A (en) | Red jujube thick syrup beneficial for improving growth and development | |
CN104872644A (en) | Non-total nutrient formula food for rheumatoid arthritis | |
CN104855989A (en) | Non-full nutritional formula food for patients with deficiency cold in spleen and stomach |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150819 |